118
Archived articleThis is an archived article from 2025 - please note that any content within the article may be out of date.

Daily Stock Market Report (Tue 29th July 2025) - BAG, CARD, GAW, GRG, STEM, MGNS, FTC, FORT, JNEO

Good morning,

Quite a large table today - we are in results season!

All done for today, thanks!

Spreadsheet accompanying this report: link (last updated: 30th June).


Companies Reporting

Name (Mkt Cap)RNSSummaryOur view (Author)

AstraZeneca (LON:AZN) (£167bn)

Interim Results

Reiterates FY25 guidance at CER: total rev (high single-digit %) & core EPS (low double-digit %).

Barclays (LON:BARC) (£51bn)

Half-year Report

2025 guidance: RoTE c. 11%. 2026 guidance: RoTE greater than 12% (I think this is unchanged).

Entain (LON:ENT) (£6.4bn)

BetMGM H1 Update & FY25 Guidance Increase

BetMGM jointly owned with MGM Resorts. Strong Q2/H1, H1 rev +35% y/y. Upgraded guidance.

Games Workshop (LON:GAW) (£5.0bn)

Full Year Results

“Exciting times”. FY25 revenue +14%, licensing rev £52.5m (LY: £31m). PBT +29% to £262.8m.GREEN (Graham)
Another set of sparkling results and lucrative licensing income continues to grow at an impressive pace. As this is such a unique company, and I would argue that it has extraordinary management, I therefore don't consider it to be overvalued at this level.

ConvaTec (LON:CTEC) (£4.9bn)

Interim Results

Confident in FY25 outlook, core organic rev growth +5.5-7%. On track for medium-term targets.

Croda International (LON:CRDA) (£4.1bn)

Interim Results

H1 in line and FY25 outlook unchanged. H1 sales +4.9%, H1 adj. operating profit +8.3%.

Unite (LON:UTG) (£3.9bn)

Interim Results

Adjusted earnings +15%, adj. EPS +3%. Reiterated guidance for adjusted EPS 47.5-48.25p.

Shaftesbury Capital (LON:SHC) (£3.0bn)

Half-year Report

“Continued strong performance.” High occupancy (2.4% of ERV to let). Leasing 9% ahead of ERV.

Inchcape (LON:INCH) (£3.0bn)

Interim Results

FY25 outlook reiterated, expecting growth at prevailing currency rates. H2 weighting.

Canal+ SA (LON:CAN) (£2.3bn)

Interim Results

H1 In line with upgraded guidance. Outlook: revenue in line, EBITA c. €515m in line.

Morgan Sindall (LON:MGNS) (£2.1bn)

Interim Results

H1 rev +7%, adj. PBT +37% (£95.9m). Net cash £390m. 2025 outlook in line.AMBER/GREEN (Graham) [no section below]
There has been little change in the market here since last month, when Roland decided to moderate his stance on it slightly, due to the higher valuation it has achieved. Checking the analyst consensus EPS chart, I see that the recent EPS upgrade for 2025 was indeed around the 10% mark (12% to be precise), as predicted by Roland. The upgrade to 2026 EPS expectations was more modest at around 7%. I tend to be cautious in this sector and P/E multiples in the teens make me nervous, so I’m inclined to agree with AMBER/GREEN here. That said, there is no denying that the numbers being published are excellent and the period-end net cash balance is comforting at £390m. I also note that the medium-term targets for two major divisions (Fit Out and Construction) have been upgraded. So I doubt that holders will be in any rush to close out their positions.

Paragon Banking (LON:PAG) (£1.88bn)

Trading Update

FY25 guidance unchanged except mortgage advances at lower end of £1.6-1.8bn range.

Greatland Resources (LON:GGP) (£1.8bn)

Quarterly Activities Report

Transformational FY25. $600m cash flow from ops in 7 months, 198,319 gold oz at AISC $1,849.

Greggs (LON:GRG) (£1.7bn)

Interim Results

Challenging footfall, weather disruption, and cost headwinds. Expectations consistent with last TU. H1 rev +7% to £1,027.7m. H1 PBT -7% to £70.4m

AMBER (Roland)
Today’s results are in line with the guidance provided in the recent profit warning and leave the full-year outlook unchanged. To get a fresh perspective, I’ve taken a broader look at the returns that have been generated so far by the elevated capex of recent years. I’m cautiously encouraged by the results and feel more positive than I thought I would about this business.
One caveat to this is that I think it’s too soon to be sure if profits have bottomed out following a series of broker downgrades. On balance, I’m remaining neutral, but I think there’s scope for an upgrade here if the company can maintain an improved outlook for FY26 and beyond.

WH Smith (LON:SMWH) (£1.4bn)

WHSmith sells Funkypigeon.com

Consistent with strategic focus on travel retail. Enterprise value £26m, net cash proceeds £21m.

Coats (LON:COA) (£1.45bn)

Further information re Acquisition of OrthoLite

Info re: previously announced acquisition, enterprise value $770m. £246m placing last week.

SSP (LON:SSPG) (£1.4bn)

Q3 Trading Update

Remain on track for results within planning assumption ranges. Operating profit £230-260m.

Uniphar (LON:UPR) (£850m)

HY Trading Update

H1 EPS ahead of expectations. Enters H2 with strong momentum. Lower interest rates are a tailwind.

A G Barr (LON:BAG) (£789m)

Trading Statement

Full year expectations unchanged. H1 revenue +3%. Boost (energy drinks) growing at double gifts, IRN-BRU flat. H2 to see strong y/y revenue growth. Acquisition: 50.1% equity stake in Innate-Essence Ltd, for £15m. Innate-Essence is the home of “The Turmeric Co.”, a specialty health drinks brand.GREEN (Graham) [no section below]
This IRN-BRU maker received a glowing review from me in March. It’s far too early to get clarity on the full-year outcome (e.g. will adjusting items be lower than last year?) but today’s update confirms that the company remains on track. H1 revenue growth is modest (3%) and some improvement will be needed in H2 to meet full-year expectations (nearly 5%), with higher marketing spend planned to achieve this. It’s the quality and resilience of the business that keeps me positive and I note the improvement in the H1 adjusted operating margin to 15% (H1 last year: 13%). The forecast P/E multiple is 15x for a stock with a QualityRank of 96 and a healthy net cash position.

James Halstead (LON:JHD) (£673m)

Trading Update

FY25 sales and profits to be slightly below FY24 levels, but within range of market exps.

Forterra (LON:FORT) (£391m)

Interim Results

SP +11%
Rev +20%, adj PBT +82% to £16.6m.
Market share remains below 2022 levels, but “demand for most products” is now expected to be ahead of expectations.
FY25 guidance upgraded:
- Adj PBT to be “significantly ahead of previous expectations”

AMBER/GREEN (Roland) [no section below]
I was AMBER/GREEN on Forterra in May, when the company flagged up rising brick industry volumes.
Today’s results confirm “strong volume growth” in H1 and modest price increases, highlighting a 14% YoY increase in UK brick industry volumes to 31 May.
Brick shipments are a relatively early indicator of housebuilding demand, relative to – say – carpets and appliances. So perhaps this is a sign that housebuilding activity is starting to firm up, although this does seem slightly at odds with the more neutral tone taken by listed housebuilders recently.
In any case, today’s numbers read well to me and I think it’s worth noting that forecast profits for the current year are less than half the level achieved in 2019-2022 (excl. 2020). If demand continues to firm up then pricing power and plant utilisation could improve, supporting positive operating leverage and higher margins.
The only caveat to this – highlighted in today’s results – is “the fragility of the UK economy” and the impact it could have on housing sales.
I don’t see any reason to change my moderately positive view on Forterra today.

Restore (LON:RST) (£350m)

Half year 2025 results

Rev +15%, adj PBT +10% to £18m. Leverage 1.9x. FY outlook unchanged.

Filtronic (LON:FTC) (£332m)

Final Results

Rev +121% to £56.3m
PBT +294% to £13.4m.
Diluted EPS +329% to 6.05p

FY26 outlook in line with market exps.
Cavendish forecasts FY26 EPS -47% to 3.2p.

AMBER (Roland)
These are outstanding results, but SpaceX provided 83% of last year’s revenue. This is a situation that’s unlikely to be sustainable and Filtronic has made no secret of the fact that its cost base has increased sharply as it seeks to develop a more sustainable and diversified customer base and product range.
I admire the progress made so far and see no serious concerns today. However, earnings are expected to fall sharply this year on flat revenue, as the exceptional margins of last year to more normal levels. That leaves the stock trading on a FY26E P/E of >40, which looks high to me. I think there’s a risk Filtronic’s valuation will reset to reflect the outlook for the next couple of years. For this reason, I’m switching to neutral today.

Card Factory (LON:CARD) (£311m)

Acquisition

SP +9%
Purchasing funkypigeon.com from WH Smith for £24m (4.8x EBITDA). CARD trading in the current year is in line with expectations.
FY26 outlook: “mid-to-high single digit” adj PBT growth with flat margins vs FY25.

GREEN (Roland) [no section below]
Card Factory’s online performance has been mixed in the past and I think it’s fair to say the company has underperformed in this segment relative to its market share on the high street. Acquiring this well-established brand looks logical to me and will hopefully help Card Factory to develop a better-scaled online presence. The purchase price doesn’t look excessive, although funkypigeon.com has slightly lower operating margins and ROCE than CARD (based on last year’s Companies House accounts).
CARD’s management believe they can achieve £5m of cost savings which should help to address this. The purchase will be debt funded and I estimate will leave CARD with leverage of c.1.0x EBITDA, which I think should be manageable. The outlook for FY26 is unchanged today leaving CARD with a P/E of 6 and a dividend yield of c.6%. I’m happy to retain our positive view today.

SThree (LON:STEM) (£309m)

Interim Results

SP -7%
Rev -14% LFL, PBT -74% to £10.1m. In Contract recruitment, “Continued softness in new business activity was partially offset by strong contract extensions”. Some improvement in US/Japan. FY25 exps unchanged.
AMBER (Graham) [no section below]
We already had a H1 trading update last month, so we knew that H1 net fees would be down 14%. That update kept full-year expectations unchanged, as does today’s outlook statement. However H1 PBT is only £10.1m and this leaves the company with a lot to do in H2, and I’m therefore not surprised to see the share price under some pressure this morning. The interim dividend (5.1p) is only barely covered by H1 EPS (5.6p). I think I can (just) maintain my AMBER stance on this for now, but if we interpret today’s share price reaction and the implied H2 PBT weighting as precursors to a full-blown profit warning, AMBER/RED might be more appropriate. I still rate this as my favourite recruitment stock (due to its STEM-sector and Contract focus), but even this one is not immune to what it describes as “a persistently challenging market environment”. Negative operational leverage has kicked in and I think investors are right to worry: it’s difficult to imagine this recovering to prior levels of profitability in the near-term. There appear to be structural, not just economic problems for the recruitment sector.

Essentra (LON:ESNT) (£298m)

Interim Results

Rev -4.6%, adj PBT -29.4% to £125m. H1 in line w/ improving LFL sales. FY25 exps unch.

Literacy Capital (LON:BOOK) (£268m)

Q2 Trading Update & NAV

NAV +1.6% to 519.5p (£312.6m). Deployed £3.4m of new capital in Q2. Cash inflows exp in H2 25.

Sylvania Platinum (LON:SLP) (£195m)

Fourth Quarter Report

FY prod ahead of guidance at 81koz. EBITDA +98% to $12.9m, strong outlook in Q1 FY26.

Tristel (LON:TSTL) (£179m)

Trading Update

Y/E 30 June to be in line with exps. Rev +11%, adj PBT +23% to <£10.1m.

James Fisher And Sons (LON:FSJ) (£177m)

HY Trading Update

H1 adj op profit exp c.£11m, leverage 1.7x. FY exps unch with strengthening defence orders.

Gaming Realms (LON:GMR) (£158m)

Pre-Close Trading Update

H1 in line with exps, rev +18%, adj EBITDA +30% to £7.5m. Launched 6 new Slingo games.

Amedeo Air Four Plus (LON:AA4) (£155m)

Annual Financial Report

FY25 op profit +3.6% to $57.9m. Positive outlook for Thai Airways & Emirates assets. NAV £294m.

NWF (LON:NWF) (£84m)

Full Year Results

FY25 slightly ahead w/ adj PBT +5.6% to £13.2m. Profits up in all 3 divisions. YTD trading in line.

IG Design (LON:IGR) (£74m)

Full Year Results

Adj PBT -93% to $1.9m. Net cash $84.8m. Outlook ex-US: FY26 rev $270-280m, 3-4% op margin

Journeo (LON:JNEO) (£65m)

Trading Update

SP -3%
H1 rev -4%, adj PBT flat at £2.8m. On track for record year, FY25 outlook in line (adj PBT £5.2m). Cash £18m.
Cavendish forecasts: FY25 revenue £52m, adj. PBT £5.2m. FY26 revenue £55m, adj. PBT £5.8m.
GREEN (Graham) [no section below]
Leaving our positive stance on this unchanged after an in-line trading update. The revenue growth figure is slightly uncomfortable at minus 4%: the company explains that its New York subway contract benefited H1 last year, and will benefit H2 this year, but did not generate anything in this most recent H1 period. Cash covers a decent chunk of the market cap and provides plenty of dry powder for bolt-on M&A. In the big picture, I can't help noticing that the overall growth figures aren't too pacey, with adj. PBT set to grow by less than 10% this year, and then maybe 12% next year. But then the valuation isn't excessive either, with the stock trading at a 13.5x  next year's EPS estimate (before adjusting for cash). As this is a Super Stock, I remain happy with GREEN.

Staffline (LON:STAF) (£60m)

Interim Results

H1 rev +8.7%, PBT +100% to £0.6m. Strong new business momentum, higher temp hours.

Colefax (LON:CFX) (£45m)

Full Year Results

FY25 ahead of exps due to Q4 surge to avoid tariffs. Adj EPS 108.4p vs consensus 79.4p.

Flowtech Fluidpower (LON:FLO) (£36m)

Trading Update

H1 in line with exps with improved trading vs H2 24. FY25 outlook in line with exps.

PCI- PAL (LON:PCIP) (£32m)

Trading & Business Update & New Product Launch

FY25 adj PBT in line with exps (£0.8m). FY26 rev seen below exps at £23.5-24m (prev. £25.5m)
Novacyt SA (LON:NCYT) (£29m)HY Trading UpdateH1 rev exp £9.8m (H1 24: £10m), +2% underlying. Cash £23.8m, enough to reach +ve EBITDA.

Maintel Holdings (LON:MAI) (£29m)

Trading Update

Rev flat at £46.5m due to contract churn. Adj EBITDA -29% to £3.4m. FY25 exps unch w/ H2 weighting.

Renalytix (LON:RENX) (£24m)

Services contract with Joslin and Pharma Partner

Contracted to undertake a kidney disease research programme with Joslin and leading pharma co.

Southern Energy (LON:SOUC) (£11m)

Operations Update

Completed Gwinville GH LSC 13-13 #2 well, initial production averaged 3.6MMcfe/d (99% gas)

Smarttech247 (LON:S247) (£10m)

Contract Wins and Renewals worth €1.53m

Various contracts from 6mo to 3y. Cavendish broker estimates unchanged today.



Graham's Section

Games Workshop (LON:GAW)

Up 6% to £161.70 (£5.3bn) - Annual Report - Graham - GREEN

It’s not possible to criticise these results:

AD_4nXfkZ8eqnir_659YIP8yROkOKaahWg2Sh28uwguT6_QWRI2Rpl3tfoNWgWUsJbWGx7w9hVIsPQOQW6PpU0w_yGuzSB73zOPfYhvYT0mBwHs3K6169d_7WEmElcdzntdZ1V0mbdHu?key=y0JAjo451cMnPxo52alNgw

I note in particular the sharp year-on-year increase in licensing revenue and licensing operating profit. This is even higher quality revenue and profit than the core operations, as it’s effectively royalties on their intellectual property.

CEO comment (and also the Outlook statement):

'After a record year, we remain focused on delivering our operational plans and working tirelessly to overcome any significant obstacles that get in the way. We will continue to give ourselves the freedom to make some mistakes, constantly working on improvements in product quality and manufacturing innovation. Despite our recent successes we will never take our hobbyists' support for granted. I wish to thank all of them together with our staff, trade accounts and broader stakeholders for their ongoing support. Exciting times.'

The strategic report contains the usual mission statements that are in no way superfluous: I wish every company could explain what it does, and why, with such clarity.

Due to time constraints, I’ll merely try to pick out a few interesting parts of this report for you.

Tariffs: no major impact.

Our current estimate is that if we did nothing, new tariffs could impact profit before tax by c.£12 million in 2025/26. This new problem will be dealt with in our normal pragmatic way. We will not change our operational plans too much… it is business as usual for Games Workshop, once again a new normal has to be accepted. It's mostly out of our control…
Tariff costs are likely to reduce our reported gross margin next year. We have a detailed operational plan to make up the c.2% gross margin shortfall through efficiencies. This is not a simple task when we are already very efficient; it may take longer than one year.

Actually, I need to add this bit because it’s hilarious:

We have been pretty solid during the year managing our cash costs and investments. Net cash generation from our core operations is at planned levels and dividends have been paid at record levels from our truly surplus cash. All in line with our detailed operational plans and policies. The exception was the news about tariffs and the cute looking pipistrelle bat that is delaying our work on our new temporary car park. We are carefully looking after the bat and we hope the uncertainty around tariffs is resolved soon.

Cash: their target “cash buffer” has increased to £85m to reflect the new three-monthly cash cost of running the company. Actual cash as of June 2025 was £133m.

Licensing: because this is so lucrative, let’s get an update.

On 10 December 2024 we announced the conclusions of our negotiations with Amazon for the adaptation of Games Workshop's Warhammer 40,000 universe into films and television series, together with associated merchandising rights. The project continues in line with our contractual agreement with Amazon. This same contract prohibits us from sharing any specific details or commercial terms…. This is a long-term partnership with Amazon and there won't be any significant news in the short term - these things take several years to bring to market.

Video games:

During the period our licensing partners launched three new PC/console games and one mobile….
We are actively exploring further console and mobile opportunities, including Space Marine 3, without losing sight of the significant long-term revenue provided by PC games…
The general backdrop still remains challenging for this market in the short term. We therefore remain cautious when forecasting royalty income. Our dedicated team, with the full support of the Warhammer Studio resources, continues to promote the depth of our IP and its unique lore and settings to potential licensing partners. Four new games were announced in the period…

And an end-note on licensing:

As a reminder, the viability and ongoing success of any of our licensing deals is broadly out of our control; they are reliant on the successful development and delivery of projects by our licensing partners.

Estimates: estimates for GAW aren’t worth too much. There are moving parts that the company itself admits can’t be forecasted, and it has never seemed too concerned about making sure that City analysts get the numbers right. In fairness to it, I think this is consistent with a business that is focused on its long-term success rather than short-term targets.

For what it’s worth, here are value metrics based on forecast numbers currently:

AD_4nXfVe5r7jTPf7o3Co1G2FlLzcU9fD1j_2tLGWjR0GhW5KmIjLJ6U9av1HyhsigHtfWlRCRfrBVofrnIYaUvF53aymcb0UquRKTLMR4EogPwoS6WJPPbQsc5g0NuSivZ6doI05S_4?key=y0JAjo451cMnPxo52alNgw

Graham’s view

I’m happy to maintain the GREEN on this as it’s a unique company with IP that can’t easily be replicated (I don’t think anyone could replicate it credibly). And it’s still sufficiently niche that I don’t think we can argue that its current success is just a fad: it owns this niche, and I don’t think that’s going to change.

I calculate ROE from these results at 74%, an increase from the 65% on the StockReport. Exciting times indeed!


Roland's Section

Greggs (LON:GRG)

Down 4% to 1,564p (£1.6bn) - Interim Results - Roland - AMBER

Today’s results from Greggs have met with a cautious response from the market. But they do appear to be in line with recently-reduced expectations (Megan covered the company’s recent profit warning here).

Today’s accounts over the 26 weeks to 28 June 2025 and show the impact of cost inflation and lower footfall, with sales up but profits down:

  • Revenue up 7% to £1,027.7m

  • Like-for-like sales in company-managed shops +2.6%

  • Like-for-like sales in franchised stores +4.8%

  • Pre-tax profit down by 14% to £63.5m

  • Diluted earnings 16% to 45.3p per share

  • Interim dividend unchanged at 19p per share

Positive LFL sales are encouraging but sales growth was not enough to overcome the pressure from higher costs – Greggs’ distribution and selling costs rose by 10% to £511m during the half year, in part presumably due to store openings.

I’m not sure what to make of the weaker LFL performance of company-managed stores, which account for around 80% of the store estate. Are franchisees selling more successfully or perhaps situated in more exciting locations?

The company says that it’s continuing to develop its menus to support growth in the post-4pm ‘daypart’. Sales made in the later part of the day now comprise 9.3% of sales (H1 24: 8.4%) and are growing faster than average. Recent menu “standout” menu introductions include the Red Pepper, Feta and Spinach Bake and Korean BBQ Chicken Flatbread.

Store openings vs profitability

One element of Greggs’ secret sauce has always been its skill at locating its stores in exactly the right places to capture passing footfall. As high street usage and out-of-town leisure locations have developed, the ‘right’ place for stores has evolved and this is reflected in the group’s changing store estate.

The company opened 87 new shops during the first half of the year, but also closed 56 (including 27 relocations). Net openings were 31, leaving the company with 2,649 shops at the end of June.

CEO Roisin Currie remains confident in the “clear opportunity” for over 3,000 UK shops in the longer term, but this is a topic that is starting to divide investors. The risk is that newer stores may start to cannibalise existing shops, resulting in cumulatively lower profitability.

The company acknowledges this in today’s results but says that in cases where a new store is opened within a mile of an existing shop, transfer of sales (cannibalisation) is just 5%, on average:

Analysis of our Greggs App customers shows that those who visit a new shop increase the overall frequency with which they visit Greggs, maintaining their visits to existing shops. In 2024 60% of our new shop openings (excluding relocations) were in areas with no other Greggs shop within a mile, with 2025 openings having a similar profile. For openings in areas with existing access to Greggs within a mile of the new shop, the transfer of sales from existing shops averaged just 5%.

To some extent, cannibalisation isn’t a problem if the company can achieve an increase in overall volumes, or sales per customer. Greggs seems confident that it’s achieving this.

From a financial point of view, what interests me is whether the extra growth is achieving satisfactory returns on capital employed – or whether further growth could end up diluting the group’s profitability.

Profitability has remained stable in recent years at a group level and Greggs’ ROCE of c.20% is certainly a respectable figure:

AD_4nXehT8gsqaquGBYBnGZrKbJdE8iVR7why2KKvbdB-8GJ7B3_DCXe_9ze2sYE_WmxY2YVLdJK_1nX0GmcH852mC6Hs5OZ9q8o7PcSwRlZKVfWvOwPA1cj8J96WIQ0boistr0IhOU-jA?key=y0JAjo451cMnPxo52alNgw

However, the size of the store estate means that the new store openings will only have a very slight impact on overall group results – at least initially. This means that we might not be able to recognise overexpansion until it’s too late to easily reverse it.

To try and get a feel for the extra profitability generated by these capital additions, I’ve estimated the increase in capital employed since 2021 and compared this with the increase in operating profit over the same period.

Greggs’ capex has been relatively high in recent years. Today’s H1 results reiterate FY25 capex guidance of £300m, up from £249m last year. Expenditure is expected to peak this year as investment in new national distribution centres is completed alongside store openings.

AD_4nXfsQ6I2WdCtXLuqsJ02lAVqvTsW1SS_Vo_qmCCmYSJxIN66gx7lEzZ6iTQIrUiuuBUmLY55iUbUjw93o0o1InvoJ9ZgfbkFpWLSuyzbtSMHyk-XFMXV98DTQvuvFRgvwQ7lkY4NvA?key=y0JAjo451cMnPxo52alNgw

Capital employed in the business has risen from around £680m to £1,045m since 2021. To date, operating profit has risen by £51m over the same period.

My sums suggest that the return on this incremental capital employed has been around 14%. That is a reasonable figure, but it is below the c.20% group average.

In fairness, I think it’s probably reasonable to argue that some of this additional capital (e.g. store openings and new manufacturing and logistics infrastructure) has not yet achieved full profitability.

On balance, I think Greggs’ growth and capex plans are worth keeping a critical eye on. There’s a risk the company will grow at the expense of profitability. But this my quick review today suggests to me that Greggs has (probably) not yet reached the stage where it’s destroying shareholder value by overexpanding.

If capex eases after this year and profits continue to rise, then this period of higher investment could start to deliver attractive returns, potentially justifying a higher rating for the shares.

FY Outlook

Today’s results include a clear statement from CEO Roisin Currie reiterating recent guidance:

The Board's expectations for the full year are consistent with the guidance provided in our last trading update on 2 July.

Unfortunately, this guidance does mean that operating profit for the current year is expected to be “modestly below” the £209m achieved last year.

I expect consensus forecasts to be largely unchanged after today, suggesting that Greggs is currently trading on a forward P/E of 13, with a 4% dividend yield:

AD_4nXcC9LfpoSFWya0mBKusxTchHUQEZwKnPLXPBK1YK9vqTJFb3qOGfrfLOXulMnVKOMfKMnKkyEKhDd4Go5gy7sFb_Isyk8pHiKWCvjqTC82nk_IJSmkGIXaw9oyiJlQF8w8FdHS-Tw?key=y0JAjo451cMnPxo52alNgw

Roland’s view

I think Greggs still needs to show that the increasing scale of its store estate and complexity of its menu will deliver attractive returns. But I have to admit I am feeling more positive than I expected to at the end of this review.

One caveat to this is that today’s results and in-line outlook statement have come less than a month after the company issued a profit warning:

AD_4nXcB2DsKdVIQEzI_e1sriY11gRfGsDsi0h4hhNb_vxCJv3RH9veLnFhvGWqG0OKryPHL1nZ8LuQX3XdI5jP-205MidPEToQpaNNQL6R2lM_hr9R_Il-j_7hISeKg1ZpyPSN34bUewg?key=y0JAjo451cMnPxo52alNgw

Earnings forecasts have trended lower since September last year and we know that, statistically, companies often underperform following profit warnings.

Arguably it’s too soon to really know if the outlook for the remainder of the year will be in line with these lower expectations. Greggs is still very much exposed to cost inflation and any weakness in consumer spending.

On the other hand, the stock has significantly de-rated over the last year. The share price is down by around 50% and the P/E has fallen from 21 to just 13:

AD_4nXfMt-okm7dc1Fxr3YOFAbDMtfDpCEH8pbBHFq_CXSjZHQCAEl7o-IBNqGj9Z6F08oeMlTGGqW2JtGiHKdVTKBaLl50UrhI-JwqktkmLD7SaSQmNi5OG7wpkDjuUXBe1ZZ5L1Moj?key=y0JAjo451cMnPxo52alNgw

I am tempted to upgrade our view to AMBER/GREEN today. But on balance, I feel that it’s probably prudent to maintain our neutral view a little longer until there’s more clarity on whether profit expectations really have bottomed out. AMBER


Filtronic (LON:FTC)

Up 1% to 154p (£338m) - Final Results - Roland - AMBER

Filtronic plc (AIM: FTC), the designer and manufacturer of products for the aerospace, defence, space and telecommunications infrastructure markets, announces its full year results for the 12 months ended 31 May 2025.

Today’s blowout results are outstanding, but are no better than expected to my eyes, with revenue and diluted earnings almost exactly matching Stockopedia's consensus figures of £56m and 6p respectively.

  • Revenue up 121% to £56.3m

  • Pre-tax profit up 294% to £13.4m

  • Diluted earnings up 329% to 6.05p per share

  • Net cash: £10.8m (FY24: £4.2m)

We know that Filtronic has gone gangbusters with SpaceX this year. The satellite internet company contributed 83% of last year’s revenue as it retrofitted Filtronic’s E-Band power amplifiers into its base stations. That’s an astonishing and risky level of customer concentration, in my view.

Investors have enthusiastically rewarded this lucrative streak of growth – Filtronic’s share price has risen by 750% in two years:

AD_4nXeDIAAZkXwJaCqQgmNX--JFYAxnt2o7kjjLOT4iX-I-oJ4lcuGnozaUIbuMLVRQC_5Ke0ro09LHRT3-jbJhlbqSvvZMBMitAlhsEWzpDQ90GUg__oQcn5JhmGSsah_yk25agINeew?key=y0JAjo451cMnPxo52alNgw

However, we know less about what may be coming next. Demand from SpaceX is expected to ease, with major new sales phases to be based on new technologies not yet in production.

Credibly, given what must have been a powerful focus on delivering for SpaceX, Filtronic has made some progress at diversifying its revenue streams over the last year.

Recent wins have included European defence primes BAE Systems and Leonardo and rival space operators such as Airbus/OneWeb and the European Space Agency.

As a result, the revenue outlook for the next year is broadly flat, with a return to growth expected in FY27.

However, achieving these wins and making the necessary investment in R&D and manufacturing has left Filtronic with a significantly increased headcount and cost base:

AD_4nXfk8LWMkKTs_KjMOqT_9xAJ06yAjizqEkBVHkbQCdPmAw1gQMa1ekdzR5JyPKyim26i52H9VD_e6etkhFf7BJ9DaelvJDSjL0-kFYw3XAjbUzwkA8VmogzEF078UNBU-0leFxu2?key=y0JAjo451cMnPxo52alNgw

Filtronic’s salary costs rose by 78% to £6.4m last year, with associated increases in other overheads.

As a result, the 24% operating margin achieved last year is expected to reset to a much lower level from FY26 onwards, resulting in a sharp fall in profits.

Outlook & Estimates

Unchanged broker forecasts today suggest earnings will fall by nearly 50% this year, with only a limited recovery in FY27.

With thanks to broker Cavendish, we have unchanged forecasts today for FY26 and newly-introduced forecasts for FY27, suggesting incremental earnings growth from FY26 (i.e. still a long way below FY25):

Source: Cavendish

Revenue

Adj EPS

FY25 Actual

£56.3m

6.05p

FY26E

£54.0m

3.2p

FY27E

£60.0m

3.9p

These forecasts suggest Filtronic’s operating margin will drop to c.15% in FY26, which I'd consider more typical for a high-tech manufacturer of this kind.

This leaves the stock trading on a FY26E P/E of 47, falling to a P/E of 39 in FY27.

49389870-86b8-4830-a149-043bddfff0ea.png

Roland’s view

I am full of admiration for what Filtronic has achieved to date and I recognise the company’s track record of outperforming expectations over the last 18 months:

AD_4nXdQFZHU6EW6URTsbGjTftMAY6PW7W_UmLEhYu2xGzGb3mVQV6ps-fLXeMppB6WaeLL-IfjoOCOXlYJpG1hdJBIdaL1sVRfJWTtIVmdq7dJ7IMJYLmOki_tjOuD-NXqVpEPmElE5vg?key=y0JAjo451cMnPxo52alNgw

However, I think it’s fair to say that this has largely been achieved from single product sales to a single customer, resulting in an exceptional and potentially unrepeatable level of profitability.

This level of concentration carries a lot of risk and I think Filtronic has done quite well to start mitigating this while still delivering to SpaceX’s satisfaction.

However, when looking ahead, I think it makes sense to value the business based on expectations for a more diversified revenue base. This seems likely to entail lower margins, as the company spends more on R&D and produces a more mixed range of products (in lower volumes) for a variety of customers.

I have maintained an AMBER/GREEN view on Filtronic for some time in hope of an upgrade to the outlook for FY26. But this has not been forthcoming and I can’t help noting that share price momentum has weakened recently, with a higher proportion of sellers than usual in recent weeks:

AD_4nXf46kdQkAMO58tZ67hIwuucPgS5iQNrnhWWRkQa5PhylQqBELu8aoX0L65TbaCPz50Xpsch7v2GEqzPLM5QAJz1D3Vf5Ch4FY-lsU5CFkXlgXunmYI9WuWZ2PYVYshsCUX0pZpA?key=y0JAjo451cMnPxo52alNgw

On balance, I think there’s a risk Filtronic’s valuation will reset to reflect a more normalised pattern of growth and profitability.

I’d probably be positive on the stock below 100p, as I do see this as a potential long-term growth story. However, at current levels, I don’t feel I have any choice but to adopt a neutral view after today’s results. AMBER

Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

42 comments


Avatar for Retail Punter

another shocking drop in Novo Nordisk shares today! you might think that large cap pharma shares are safe!

5
Avatar for kam31572

Crazy, they are still growing faster than most large cap pharma competitors. Best to low ball forecast and over archive.  

1
Avatar for Mark Carter

Novo Nordisk A/S (NYQ:NVO)   A top 10 holding of FundSmith, so the fund is going to take a bit of a hit there.

"Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again" Down 20%. Crikey. 

"The Danish drugmaker now expects 2025 sales growth of 8–14% and operating profit growth of 10–16% at constant exchange rates (CER), down from prior forecasts of 13–21% and 16–24%, respectively."

The shares seem to be trading on a PE of 15, which seems very reasonable for profits growing in double digits.

Bizarre.
4
Avatar for rmillaree

Its almost as if Trump is making it so that US companies (that "pay their bounty to Mr T") do well and non us companies will be royally shafted  - must admit thats lazy comments i havent looked into detail as to why the news aint so good - copilot seems to think todays drop has little to do with trump so perhaps my thoughts might be wide of the mark.

1
Avatar for Retail Punter

Novo Nordisk seem to have a US manufacturing facility  which is being extended. So I don't see US tariffs as a problem. Management comment: “For Wegovy in the US, the sales outlook reflects the persistent use of compounded [drugs], slower than expected market expansion and competition,”

0
Avatar for Harry Hindsight

I keep notes on sectors. This one avoiding as too complex. 

Novo head start with Wegovy and Ozempic.

Lilly catching up with Zepbound and to overtake 2027 as superior.

The breakthrough in the development of obesity drugs came out of a niche class of drugs developed to treat diabetes, called GLP -1 (glucagon-like peptide -1) agonists. These drugs mimic naturally-occurring hormones which regulate appetite and blood sugars.

Competition from ‘compounders’ who actually produce the stuff for the 'big boys' but legally restricted from producing their generic products unless allowed, which the FDA has allowed in times of shortage. 

Oral solutions will be more palatable than injectables so the battleground. 

Some risk, from RFK Jnr on big pharm push back and more support for natural products. 

That said it has potential to change people’s lives with applications beyond weight loss to diabetes, dementia, heart health etc.  But don't expect to take a pill and lose weight so you can eat more.  We are our own worst enemy (sorry lost the plot at the end). 

4
Avatar for Spider1234

Synectics (LON:SNX) down again, Whitehall still offloading?

Maybe i have got this wrong...

7
Avatar for GAZ

I hope not as is my largest holding by far!

3
Avatar for shanklin100

Hi Graham

In the summary table, re Games Workshop (LON:GAW) , did you mean, "I therefore don't consider it to be overvalued at this level."

HTH. Cheers, Martin

7
Avatar for FREng

Off topic - I'm puzzled by the way broker consensus is used in screening. The values are 1-5 with 1 being strong buy and 5 strong sell. So a change in broker consensus in the screener (or in comparisons of shares in the Compare feature in StockReports) shows a lower value as better than a higher value (eg  -1 is much better than +2) That's counterintuitive - why is it set up this way?

1
Avatar for Edward Croft

iwright - I had just noticed the same.

"significantly ahead" too.

I've been waiting to see traction from the brickie sector given the "1.5m homes in this parliament ambition".

7
Avatar for FREng

How is the increase in brick deliveries reported by Forterra (LON:FORT) consistemt with the rather downbeat outlook from builders and analysts?

9
Avatar for iwright7

Yes it seems counter intuitive for Forterra (LON:FORT) to be "signifigantly ahead".  Perplexity has some of the answers....

....Forterra's brick sales are up in 2025 due to a combination of recovering demand from housebuilders, increased housing construction activity, and successful implementation of price increases.

Key contributing factors include:

  • Stronger Housing Demand: The UK housing market rebounded in 2025, with volume housebuilders driving increased demand for bricks as new housing starts and completions rose.
  • Higher Revenues and Market Share: Forterra saw revenues rise by over 20% in the first half of 2025, corresponding with a 14% increase in brick sales volume, substantially ahead of 2024 benchmarks.
  • Price Increases: The company successfully passed on price increases to the market, which contributed both to revenue growth and improved profitability.
  • Capacity Expansion and Operational Investments: Forterra boosted production at facilities like Desford and Wilnecote to meet rising demand, preparing both kilns at Desford for simultaneous operation and investing significantly to reinstate and upgrade manufacturing capacity.
  • Depleting Inventories: As inventories declined and customer demand increased, Forterra actively ramped up capacity to avoid shortages and capitalize on market momentum
4
Avatar for Edward Croft

Honestly - I have no idea, and am no sector expert.   Progressive have a note out today. 

I've just been mulling over the idea that the brickies could do well in a home construction boom.  No sign of that yet of course - just leaning on the rather lofty "1.5m" claim from the gov.

What I do know is that news and individual stocks often lead the way.  Perhaps Forterra, as a more market leading brickie is seeing the front end of any volume improvements. 


7
Avatar for John LA

Housebuilding 

0
Avatar for GAZ

Sell end of May??

Every year I think the same at this time of year. Just watching my portfolio dribble away June-August. Very frustrating indeed.

9
Avatar for Dodds98

Greggs (LON:GRG) More and more youngsters and builders swapping the traditional sausage and bacon bap for the gym and kale smoothies? 

3
Avatar for rmillaree

Greggs (LON:GRG)

Greggs certainly dont not move with the times - eg there are salad boxes and pasta and rice bowls etc. If stuff is popular enough and simple enough to make decent chance it may come on the menu eventurally.

Having said that Greggs is very much "is was it is" - i think everyone who shops there knows its  a guilty pleasure  (i suspect their pasta boxes are high in fat !!). In that regard i think they should be able to survive scenario where people are eating more healthily.  Perhaps some headwinds here at worst - if they could have a "super healthly range though" perhaps that would do the job ref that group if it becomes big enough.

I suspect if Greggs did Kale and smoothies they would be able to beat the independents on price or at least match them.

I dont own at present but its starting to look tempting again - i would say that full bounceback to peak profits will be hard slog due to rises in ers NI - business rates - power and there other core expenses. I do very much think they have headwinds beyond their control at present that likely will subside at some point - and growth should return. I would say the lowering of the p/e ration that has happened is also natural as they move towards "market saturation". In that regard i would be happy they simply use excess cash or buy back shares - sometimes i wander if thats a common problem with listed company directors - the need to convince the market growth is great - if growth is not so great (due to eating into existing outlets profits) or moving into new areas beyond core competence. imho sometimes running efficient sustainable business and paying out excess is not all bad

6
Avatar for Edward Scott

Games Workshop (LON:GAW) I hold. Not sure how much of a dent it will put in the finances of GAW but the latest rule changes seem to have nerfed some player armies, (gets complicated when you have 30K and 40K story lines) together with the introduction of the "Saturnine" product line, seems to have gone down like a cup of cold sick within the fanbase.  Stores were apparently forced to purchase less popular lines in order to receive the Saturnine product which risked ending up with a stock they can't sell - some stores report Saturnine hasn't sold well.  More popular product lines seem to be out of stock also. The brand re-image from the yellow/red writing is being replaced with a cold corporate looking font which has also not been warmly received.  Die hard fans can be sensitive souls.  

21
Avatar for wildshot

That's very helpful Edward Scott re Games Workshop (LON:GAW) . I recall the RNS this morning mentioned about how their stock holding had risen and they were keen to limit the amount of money tied up in stock.

1
Avatar for charlie51

Journeo (LON:JNEO) Cavendish raise TP to 540.  Clear explanation for this morning's fall......

14
Avatar for charlie51

Journeo (LON:JNEO) To reply to my own comment the Cavendish commentary is as follows:

Journeo* / JNEO / £64m – In-line trading update

  • Journeo has released its 1st half trading update with performance in line with expectations and FY25E remains on track to be a record year for revenue and adj PBT.
  • Comparable half last year included the final £3.4m of revenue from the large New York contract, meaning the top line grew 10% organically YoY when excluding that base effect, or modestly declined 4% when including it. Adj PBT was maintained at £2.8m.
  • Operational momentum remains strong, with order intake up 25% YoY to £30m and the opportunity pipeline also rising 33% YoY to £80m, providing good visibility into 2nd half and beyond.
  • As such, we have released our maiden FY26E forecasts which show further top-line organic growth of 6% YoY to £55m. The larger scale of the business leads to Adj PBT margins increasing 0.5pp to 10.5% and sees 11% adj PBT and EPS growth.
  • We have lifted our target price from 470p to 540p by taking the latest peer group FY1 EV/EBITDA multiple of 10x and applying to Journeo’s FY2 adj EBITDA of £7.1m
  • Journeo continues to look compelling on an FY26E Adj P/E of 14x (10x ex-cash P/E) vs peers on 16x, with further upside if the £18m of cash is deployed on its advanced stage acquisition plans.

15
Avatar for Burnt Onions

Journeo (LON:JNEO)

Charlie, I wouldn't stress over the fall today, these are thin illiquid summer markets that are easily influenced by even modest selling...

The direction of travel is what matters here and for two years they have put out positive RNS after positive RNS, revenues growing, profits growing, cash balance growing, order book growing and it's still modestly rated.

I think a step change could come with the quality of the next acquisition and given the CEO has delivered to date I see no reason to doubt their next move. 

His target was always to get revenues up to £100m pa and they are still on course for that...

15
Avatar for charlie51

Journeo (LON:JNEO) Completely aligned Burnt Onions - that said I do feel a tad frustrated by a market that responds negatively to in line or ahead expectations.  It is not efficient and negatively conducive (if one can have such a state) to overall investment sentiment - new and potential entrants may well feel discouraged from adding or taking up positions.  Older lags such live with it.

7
Avatar for Fegger

The Events Today section on each portfolio seems to have stopped being filled in . Disappointing as I found it a useful quick source of information 

1
Avatar for Fegger

Now fixed by 10.00. Used to be much earlier

0
Avatar for iwright7

Worth looking closer at the brickmaker Forterra (LON:FORT)  who surprisingly fit  Ed's Jump Strategy: Share Price +10% , Ahead and SR>75.

Progressive upgrade:  "We have raised our estimate for adjusted PBT by 21% to £33m".

18
Avatar for Silver Moon

I like the sound of that as I was thinking of selling my holding.

3
Avatar for Rusty2

Forterra (LON:FORT) not quite yet, has to be +10% at the close, on the update day.

1
Avatar for iwright7

Rusty,

I dont think its that precise about the % closing price gain, (and if it is it doesnt need to be).  Ed is quoting the closing price % because its useful metric to back test  with.  

From  Ed's 17th June Jump acticle:

Jump Rule 2 The share price jumps 10% or more on the day.

When the RNS is well ahead of expectations the danger of waiting for the end of the day is that the price drifts upwards during the day.  So I take it as a Pass if the ahead news is strong and the price hits >10 %. 

b13043eb-dc44-4c1d-87a1-262728a34971.png

8
Avatar for Simon

Before anyone says or thinks “Games Workshop (LON:GAW) is expensive based on analyst forecasts etc.” - this was their consensus view prior to today’s results (and this was AFTER the company had issued a full year trading update) 

9bdd5782-1bbf-4f72-a581-9ab11c916d8a.jpeg

The actual numbers in today results publication were £617m revenue and EPS of 594p. Enough said! 

41
Avatar for bohenie

Tough job out there for Graham today - Just peeked at Games Workshop (LON:GAW) - impressive results but so much detail it could take all day to analyse just this one company. Also looks good results from Morgan Sindall (LON:MGNS) and others

27
Avatar for GloucesterBob

Card Factory (LON:CARD) looking to buy funky pigeon.com. Is this the rocket needed to boost their on line presence?

19
Avatar for Timbo.

It does look interesting and there are promises of cost efficiencies, however they have snuck out a small profit warning in the process without any details to show how much of a miss it is 

9
Avatar for Bouden54

Card Factory (LON:CARD) They report H1 sales growth, but profit behind due to bringing forward investment. However, we know that the business is heavily H2 weighted and they confirm they are on target to meet FY expectations. Don't really see any issues here but will be interesting to see how the market interprets all this, alongside today's acquisition. 

26
Avatar for iain1234

Card Factory (LON:CARD) When I read about the acquisition, I did start running over the funky pigeon music ditty in my head, again and again, despite never using them. That’s got to be worth a couple of quid? 

10
Avatar for rmillaree

Card Factory (LON:CARD)

I did start running over the funky pigeon music ditty in my head,

i musty be showing my age when i have no idea what the funky pigeon ditty is - i simply default to the funky gibbon - if they havent copied that ditty they probably should have done  and had  a pigeon fighting off and replacing the gibbon.

7
Avatar for iain1234

Thanks for that- running both funky gibbon and pigeon music over and over now…..maybe that’s a plan. Lots of “get well soon from your psychotic episode” card sales?

4
Avatar for muckshifter

The part of the RNS that made me smile was the promise to pay a progressive dividend of three times adjusted earnings.  Perhaps they need a new proof reader as the absence of a word shouldn't be missed.

2
Avatar for LindenP

Be interesting to see how markets react to WH Smith (LON:SMWH) selling this business. 

2
Avatar for rmillaree

Card Factory (LON:CARD)

I find it hard to get excited about this deal - yes sales from acquired entity are perhaps not too bad at face value. The acquired business will likely no longer have the free sales push via WH Smith sometime in the future which I suspect might have driven a decent % of sales?  - ok card can perhaps push stuff the way of the acquired unit but that will be at the expense of their own brand sales. Don’t get me wrong management here should hopefully have a cunning plan - let’s not hope it’s them simply trying to buy low margin online sales in crowded marketplace - if this brings own manufacturing and distribution savings then perhaps it could be a compelling fit - if they can run this and online with 1 set of overheads.

11
Avatar for Tortoise investor

I don't think WH Smith (LON:SMWH) really pushed Funky over the last 12-24 months - they openly said it was not core business that they wanted to get rid of. 

The opportunity could be to undercut Moonpig (LON:MOON) given their operating margins.

4
Get the free newsletter